Canadian Collaborative Research Network
Avatar

The Post-MI Patient – Should We Liberalize the Use of PCSK9 Inhibitors and Colchicine?

By Canadian Collaborative Research Network FEATURING Milan Gupta
By Canadian Collaborative Research Network FEATURING Milan Gupta
182 views
August 13, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

26:13
Lilly Diabetes

A Journey through Five Phase 3 Clinical Trials for a T2D Incretin Me…

Feat. B. Hirsch

Featured Video

02:17
Novartis Cardiology

Understanding Acquisition and Billing for a Non-Statin Lipid-Lowerin…

Feat. B. Buell

Related Content

AUTOPLAY
16:57
William White

Ambulatory Blood Pressure Monitoring

26:11
13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff
12:04
Stephen Kopecky

Role of PCSK9 Inhibitors in Diabetes

42:28
Scripps Health

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Feat. M. Budoff
18:43
Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue
59:01
The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross
19:16
The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez
21:34
Canadian Collaborative Research Network

Should Colchicine Become Standard Therapy for CAD?

Feat. P. Ridker
24:02
Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus
14:39
Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice
08:44
AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston
19:24
National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg
21:27
Scripps Health

Lipids Update: Current Guidelines for Lipid Management

Feat. S. R. Mehta
14:50
AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray
34:20
Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester
45:45
Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald
31:02
Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar
28:05
Michael Makover

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

19:20
National Lipid Association

Colchicine: Now and What’s Next?

Feat. C. Ballantyne
40:49
University of Minnesota

ECMO for Refractory Cardiac Arrest: Mobile MN Community Efforts and …

Feat. D. Yannopoulos